These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12616671)

  • 1. Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil.
    Zhao Q; Xie C; Pesco-Koplowitz L; Jia X; Parier JL
    J Clin Pharmacol; 2003 Feb; 43(2):180-6. PubMed ID: 12616671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Reyes JF; Preskorn SH; Khan A; Kumar D; Cullen EI; Perdomo CA; Pratt RD
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):50-7. PubMed ID: 15496223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.
    Nagy CF; Kumar D; Perdomo CA; Wason S; Cullen EI; Pratt RD
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):25-33. PubMed ID: 15496220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses.
    Tiseo PJ; Perdomo CA; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):30-4. PubMed ID: 9839763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):35-9. PubMed ID: 9839764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses.
    Tiseo PJ; Perdomo CA; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):25-9. PubMed ID: 9839762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent administration of donepezil HCl and digoxin: assessment of pharmacokinetic changes.
    Tiseo PJ; Perdomo CA; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):40-4. PubMed ID: 9839765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers.
    Boinpally R; Chen L; Zukin SR; McClure N; Hofbauer RK; Periclou A
    Clin Drug Investig; 2015 Jul; 35(7):427-35. PubMed ID: 26016820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative fasting bioavailability of dispersible and conventional tablets of risperidone: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy male Chinese volunteers.
    Huang M; Shen-Tu J; Hu X; Chen J; Liu J; Wu L
    Clin Ther; 2012 Jun; 34(6):1432-9. PubMed ID: 22595151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.
    Huang F; Lasseter KC; Janssens L; Verhaeghe T; Lau H; Zhao Q
    J Clin Pharmacol; 2002 Dec; 42(12):1341-51. PubMed ID: 12463729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil.
    Periclou AP; Ventura D; Sherman T; Rao N; Abramowitz WT
    Ann Pharmacother; 2004 Sep; 38(9):1389-94. PubMed ID: 15266045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single-dose thioridazine in young volunteers.
    Ravic M; Warrington S; Boyce M; Dunn K; Johnston A
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):34-40. PubMed ID: 15496221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone: effects of formulations on oral bioavailability.
    Gutierrez R; Lee PI; Huang ML; Woestenborghs R
    Pharmacotherapy; 1997; 17(3):599-605. PubMed ID: 9165565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of potential pharmacokinetic drug-drug interaction between armodafinil and risperidone in healthy adults.
    Darwish M; Bond M; Yang R; Hellriegel ET; Robertson P
    Clin Drug Investig; 2015 Nov; 35(11):725-33. PubMed ID: 26387027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration.
    Tiseo PJ; Rogers SL; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):13-8. PubMed ID: 9839760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers.
    Mahatthanatrakul W; Sriwiriyajan S; Ridtitid W; Boonleang J; Wongnawa M; Rujimamahasan N; Pipatrattanaseree W
    J Clin Pharm Ther; 2012 Apr; 37(2):221-5. PubMed ID: 21518375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients.
    Reyes JF; Vargas R; Kumar D; Cullen EI; Perdomo CA; Pratt RD
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):9-17. PubMed ID: 15496218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.